EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice

Wei-Chun Chou, Qiran Chen, Long Yuan, Yi-Hsien Cheng, Chunla He, Nancy A Monteiro-Riviere, Jim E Riviere, Zhoumeng Lin

Journal of Controlled Release · 2023-09 · 361 · 53-63

DOI: 10.1016/j.jconrel.2023.07.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-09. Verfasst von Wei-Chun Chou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32608, USA; Ce…. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms. Die Arbeit wurde bisher 227-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIBIB NIH HHS, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The critical barrier for clinical translation of cancer nanomedicine stems from the inefficient delivery of nanoparticles (NPs) to target solid tumors. Rapid growth of computational power, new machine learning and artificial intelligence (AI) approaches provide new tools to address this challenge. In this study, we established an AI-assisted physiologically based pharmacokinetic (PBPK) model by integrating an AI-based quantitative structure-activity relationship (QSAR) model with a PBPK model to simulate tumor-targeted delivery efficiency (DE) and biodistribution of various NPs. The AI-based QSAR model was developed using machine learning and deep neural network algorithms that were trained with datasets from a published "Nano-Tumor Database" to predict critical input parameters of the PBPK model. The PBPK model with optimized NP cellular uptake kinetic parameters was used to predict the maximum delivery efficiency (DEmax) and DE at 24 (DE24) and 168 h (DE168) of different NPs in the tumor after intravenous injection and achieved a determination coefficient of R2 = 0.83 [root mean squared error (RMSE) = 3.01] for DE24, R2 = 0.56 (RMSE = 2.27) for DE168, and R2 = 0.82 (RMSE = 3.51) for DEmax. The AI-PBPK model predictions correlated well with available experimentally-measured pharmacokinetic profiles of different NPs in tumors after intravenous injection (R2 ≥ 0.70 for 133 out of 288 datasets). This AI-based PBPK model provides an efficient screening tool to rapidly predict delivery efficiency of a NP based on its physicochemical properties without relying on an animal training dataset.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesNeoplasmsMiceAnimalsTissue DistributionArtificial IntelligenceModels, Biological

Stichwörter der Autor:innen

Artificial intelligenceDrug deliveryMachine learningNanomedicineNanotechnologyPhysiologically based pharmacokinetic modeling

Autor:innen und Institutionen

  • Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32608, USA; Center for Environmental and Human Toxicology, University of Florida, Ga…
  • Institute of Computational Comparative Medicine, Kansas State University, Manhattan, KS 66506, USA.
  • Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32608, USA; Department of Biostatistics, College of Public Health and Health Profess…
  • Nanotechnology Innovation Center of Kansas State, Kansas State University, Manhattan, KS 66506, USA; Center for Chemical Toxicology Research and Pharmacokinetics, North Carolina State University, Raleigh, NC 27606, USA.
  • Center for Chemical Toxicology Research and Pharmacokinetics, North Carolina State University, Raleigh, NC 27606, USA; 1Data Consortium, Kansas State University, Olathe, KS 66061, USA.

Förderung

  • NIBIB NIH HHS
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institutes of Health

Zitieren

APA

Chou, W. C., Chen, Q., Yuan, L., Cheng, Y. H., He, C., Monteiro-Riviere, N. A., Riviere, J. E., & Lin, Z. (2023). An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice. Journal of Controlled Release, 361, 53-63. https://doi.org/10.1016/j.jconrel.2023.07.040

Vancouver

Chou WC, Chen Q, Yuan L, Cheng YH, He C, Monteiro-Riviere NA, et al. An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice. Journal of Controlled Release. 2023;361:53-63. doi:10.1016/j.jconrel.2023.07.040

BibTeX
@article{Chou2023,
  author = {Chou, Wei-Chun and Chen, Qiran and Yuan, Long and Cheng, Yi-Hsien and He, Chunla and Monteiro-Riviere, Nancy A and Riviere, Jim E and Lin, Zhoumeng},
  title = {An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice},
  journal = {Journal of Controlled Release},
  year = {2023},
  volume = {361},
  pages = {53--63},
  doi = {10.1016/j.jconrel.2023.07.040}
}
Kostenlos starten →